期刊文献+

血浆置换联合血液透析滤过治疗重症急性胰腺炎临床疗效分析 被引量:8

Clinical efficacy analysis on plasma joint hemodialysis filtration treatment for severe acute pancreatitis
在线阅读 下载PDF
导出
摘要 目的探讨血浆置换(PE)联合血液透析滤过(CHD)治疗重症胰腺炎(severe acute pancreatitis、SAP)的临床疗效。方法将62例SAP患者随机分为治疗组(A组)和对照组(B组),A组32例采用内科综合治疗+PE+CHD治疗;B组30例采用内科综合治疗。观察治疗前后临床症状体征及白细胞(WBC)、纤维蛋白酶原(Fib)、血淀粉酶(LDH)、血糖(Glu)、肝肾功能、内毒素(LPS)、肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)、白细胞介素8(IL-8)结果。结果两组在临床症状体征改善、食欲好转方面差异无统计学意义(P>0.05);两组患者WBC、LDH、Glu和ALT在治疗后7天均有不同程度的降低,Fib升高,其中治疗组更明显,差异有统计学意义(P<0.01);Cr在A组明显降低,在B组明显升高,但差异无统计学意义(P>0.05);A组治疗后LDH低于B组(185.12±45.02)U/L vs(264.31±39.42)U/L(P<0.01)。两组治疗后血清LPS、TNF-α、IL-6、IL-8水平均明显下降,与治疗前比较差异有统计学意义(均P<0.01)。两组间治疗后IL-6、IL-8比较差异有统计学意义(P<0.01)。结论 PE联合CHD治疗SAP能迅速改善临床症状体征,显著降低WBC、LDH、Glu、LPS、TNF-α、IL-6、IL-8水平,升高血清Fib,提高患者存活率。 Objective To explore the effect of plasma exchange(PE) joint hemodialysis(HDF) treatment for severe acute pancreatitis(SAP).Methods 62 cases were randomly divided into treatment group(A group) and control group(B group),32 patients in A group got medical treatment + PE + HDF treatment,30 cases in control group comprehensive internal medicine treatment.Clinical symptoms were observed before and after treatment and routine blood(WBC),blood amylase,protease,fiber LDH,fiber protease original(Fib),blood sugar(Glu),endotoxin(LPS),tumor necrosis factor alpha(TNF-α) and interleukin(IL-6) and interleukin(IL-8) were detected.Results Two groups showed no statistical significance in the clinical symptoms and signs in treatment(P0.05),WBC,LDH and Glu in 7 days after treatment decreased in different degrees,but Fib increased,in treatment group they were apparent with statistic significance(P0.01),ALT,Cr declined,but the differences were not statistically significant(P0.05).LDH in A group after treatment was lower than that in B group(185.12±45.02) U/L vs(264.31±39.42) U/L(P0.01).After treatment,LPS,TNF alpha,IL-6,IL-8 levels were obviously decreased in both groups(P 0.01).After treatment,the comparisons of IL-6,IL-8 between two groups were statistically significant(P0.01).Conclusion PE joint CHD treatment can rapidly improve the clinical symptoms and signs of SAP,significantly reduce WBC and LDH,Glu LPS,TNF-α,IL-6,IL-8 level,raise Fib,improve the survival rate of the patients.
出处 《临床荟萃》 CAS 2011年第9期760-762,765,共4页 Clinical Focus
关键词 胰腺炎 血浆置换 肾透析 pancreatitis plasma exchange renal dialysis
  • 相关文献

参考文献7

二级参考文献16

  • 1李涛,叶本功.急性胰腺炎60例临床分析[J].广西医学,2005,27(1):105-106. 被引量:6
  • 2[1]Hirassawa H, Sugai T, Oda S, et al. Continous hemodiafiltration can remove humoral mediators from the blood stream of patients with SIRS/MODS. Abstr. Blood Purif,1997, 15:136
  • 3[2]Heering P, Morgera S, Schmitz G, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med, 1997, 23:288
  • 4[3]Kouche K,Cavadore P,Portales P, et al. Continous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNF-α and IL-6 plasma concentrations. J Neprol, 2002, 15:150
  • 5[4]Sander A,Armbruster W,Sander B, et al. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but not alter IL-6 and TNF-α plasma concentrations. Intensive Care Med, 1997, 23:878
  • 6[6]Sieberth HG,Kierdorf HP. Is cytokine removal by continuous hemofiltration feasible? Kidney Int. 1999, 56(Suppl. 72): S79
  • 7[7]Silvester W. Mediator removal with CRRT: complement and cytokines. Am J Kidney Dis, 1997, 30 (Suppl.4): S38
  • 8[8]Sibbald WJ, Vincent JL. Round table conference on clinical trial for the treatment of sepsis. Crit Care Med, 1995, 23:394
  • 9[10]De vriese AS,Colardyn FA,Philipp JJ, et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol, 1999, 10: 846
  • 10[11]Morgera S,Stowinski T,Melzer C, et al. Renal replacement therapy with high-cutoff hemofilters: Impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis, 2004, 43: 444

共引文献107

同被引文献101

引证文献8

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部